Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 9 hours ago
Decision of EMA on adoption by analogy of Commission decision C(2026) 634 final of 5 February 2026 amending Decision C(2002) 98 fixing rates of daily subsistence allowances and ceilings for reimbursements of hotel expenses for missions outside EU
about 9 hours ago
Decision of EMA on adoption by analogy of Commission decision C(2026) 634...
Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of authorisation: 16/02/2024, Revision: 4, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of...
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Date of authorisation: 30/06/2025, Revision: 2, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Reyataz, atazanavir sulfate, Date of authorisation: 01/03/2004, Revision: 58, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Reyataz, atazanavir sulfate, Date of...
Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 33, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation...
Human medicines European public assessment report (EPAR): Lytenava, bevacizumab, Date of authorisation: 27/05/2024, Revision: 4, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Lytenava, bevacizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rekovelle, follitropin delta, Date of authorisation: 12/12/2016, Revision: 7, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Rekovelle, follitropin delta, Date of...
Human medicines European public assessment report (EPAR): Mirapexin, pramipexole, Date of authorisation: 23/02/1998, Revision: 43, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Mirapexin, pramipexole, Date of authorisation...
CAT quarterly highlights and approved ATMPs - June 2026
about 13 hours ago
CAT quarterly highlights and approved ATMPs - June 2026
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 12 May 2026, 09:30 (CEST) to 12 May 2026, 13:30 (CEST)
about 13 hours ago
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party...
Committee for Medicinal Products for Veterinary Use (CVMP): 14-16 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 14 April 2026 to 16 April 2026
about 15 hours ago
Committee for Medicinal Products for Veterinary Use (CVMP): 14-16 April 2026, European...